Drug Development Phase 2 Clinical Trials Double-Blinded Randomized Clinical Trials Cancer Treatment Trials Phase III Clinical Trials Drug Safety
Novel immune cell-based treatments have demonstrated significant tumor reduction in patients with the most aggressive brain cancer, according to recent studies.